Related Experiment Video
Updated: Jul 26, 2025

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
Pulmonary Expression of Interleukin-17 Contributes to Neutrophil Infiltration into the Lungs during Pneumonic Plague
Hayley M Theriot1, Priyangi A Malaviarachchi1, Madeleine G Scott1
1Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Abstract:
Inhalation of respiratory droplets infected with Yersinia pestis results in a rapidly progressing and lethal necrotic pneumonia called primary pneumonic plague. Disease manifests as biphasic, with an initial preinflammatory phase with rapid bacterial replication in the lungs absent readily detectable host immune responses. This is followed by the onset of a proinflammatory phase that sees the dramatic upregulation of proinflammatory cytokines and extensive neutrophil accumulation in the lungs. The plasminogen activator protease (Pla) is an essential virulence factor that is responsible for survival of Y. pestis in the lungs. Our lab recently showed that Pla functions as an adhesin that promotes binding to alveolar macrophages to facilitate translocation of effector proteins called Yops into the cytosol of target host cells via a type 3 secretion system (T3SS). Loss of Pla-mediated adherence disrupted the preinflammatory phase of disease and resulted in early neutrophil migration to the lungs. While it is established that Yersinia broadly suppresses host innate immune responses, it is not clear precisely which signals need to be inhibited to establish a preinflammatory stage of infection. Here, we show that early Pla-mediated suppression of Interleukin-17 (IL-17) expression in alveolar macrophages and pulmonary neutrophils limits neutrophil migration to the lungs and aids in establishing a preinflammatory phase of disease. In addition, IL-17 ultimately contributes to neutrophil migration to the airways that defines the later proinflammatory phase of infection. These results suggest that the pattern of IL-17 expression contributes to the progression of primary pneumonic plague.
Insights
Yersinia pestis uses the Pla protein to suppress Interleukin-17 (IL-17) during early pneumonic plague. This suppression limits neutrophil response, allowing rapid bacterial growth and establishing the preinflammatory phase of infection.
Area of Science:
- Microbiology
- Immunology
- Pathogenesis
Background:
- Primary pneumonic plague, caused by Yersinia pestis, is a lethal lung infection characterized by biphasic disease progression.
- The early phase involves bacterial replication without significant immune response, followed by a proinflammatory phase with cytokine upregulation and neutrophil influx.
- The Yersinia pestis virulence factor, plasminogen activator protease (Pla), is crucial for bacterial survival and virulence in the lungs.
Purpose of the Study:
- To investigate the specific host immune signals suppressed by Yersinia pestis during the preinflammatory phase of pneumonic plague.
- To elucidate the role of Interleukin-17 (IL-17) in the pathogenesis of primary pneumonic plague.
- To understand how Pla-mediated suppression of IL-17 influences disease progression.
Main Methods:
- Investigated the interaction of Pla with alveolar macrophages and the translocation of Yops via the type 3 secretion system (T3SS).
- Analyzed the impact of disrupted Pla-mediated adherence on early disease phases and neutrophil migration.
- Assessed the role of IL-17 suppression by Pla in alveolar macrophages and pulmonary neutrophils during infection.
Main Results:
- Early suppression of IL-17 by Pla in alveolar macrophages and pulmonary neutrophils limits neutrophil migration to the lungs.
- Disruption of Pla-mediated adherence leads to premature neutrophil migration.
- IL-17 contributes to neutrophil migration to the airways during the later proinflammatory phase of infection.
Conclusions:
- Early Pla-mediated suppression of IL-17 is critical for establishing the preinflammatory phase of primary pneumonic plague.
- The modulation of IL-17 expression by Yersinia pestis dictates the transition between disease phases.
- Targeting IL-17 pathways may offer therapeutic strategies against pneumonic plague.
More Related Videos
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Related Concept Videos
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...